Drug Standards
![Medchemexpress LLC Glycine, N-[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-, phenylmethyl ester | 81110-73-8 | 99.94% | 385.48 | 1 ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000384598-logo.png-250.jpg){kind=logo}
Medchemexpress LLC Glycine, N-[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-, phenylmethyl ester | 81110-73-8 | 99.94% | 385.48 | 1 ML
Racecadotril (Acetorphan) is a neutral endopeptidase (NEP) inhibitor and an antidiarrheal agent. Its active metabolite, Thiorphan, inhibits purified NEP activity. Racecadotril is rapidly metabolized in mice and shows efficacy in a rat model of castor oil-induced diarrhea.
Sigma Aldrich Fine Chemicals Biosciences Ethopabate British Pharmacopoeia (BP) Reference Standard | 59-06-3 | MFCD00075809 |
Ethopabate British Pharmacopoeia (BP) Reference Standard | Mol Wt: 237.25 | 59-06-3 | MFCD00075809 |
Medchemexpress LLC Atazanavir (sulfate) | 229975-97-7 | 99.7% | 802.93 | 50 MG
Atazanavir sulfate is a highly selective and orally active HIV-1 protease inhibitor with blood-brain barrier permeability. It functions as both a substrate and inhibitor of CYP3A4, and also inhibits P-glycoprotein (P-gp). Additionally, it is a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. This compound has demonstrated the ability to inhibit cardiac fibrosis and hyperlipidemia, and induce malignant glioma cell death.
- Highly selective and orally active
- HIV-1 protease inhibitor
- Crosses the blood-brain barrier
- Inhibitor and substrate of CYP3A4
- Inhibits P-glycoprotein (P-gp)
- SARS-CoV 3CLpro inhibitor (IC50 of 3.49 μM)
- Inhibits cardiac fibrosis
- Inhibits hyperlipidemia
- Induces malignant glioma cell death
HARWICK STANDARD DISTRIBUTION SYNPRO ZN STEARATE DLG-10-25LB
NC3781364 SYNPRO ZN STEARATE DLG-10-25LB
Selleck Chemical LLC Gemcitabine S1714-1g
Gemcitabine a nucleic acid synthesis inhibitor is a very potent and specific deoxycytidine analogue used as chemotherapy Gemcitabine induces a potent p53-dependent apoptosis
Crescent Chemical Co Inc QUININE 100 MG
Quinine Pharma./veter. comp. (WS) CAS 130-95-0 Molecular Weight - 324.4168 Storage - RT Catalog Num - DRE-C16706900 chemical
Apexbio Technology LLC Tadalafil, 100mg. Cas: 171596-29-5 MFCD: MFCD07771966. PDE5 inhibitor
Tadalafil, also known as IC351 or Cialis, is a potent, reversible and competitive small-molecule inhibitor of phosphodiesterase 5 (PDE5). 171596-29-5. MFCD07771966
Crescent Chemical Co Inc SULFANITRAN 250 MG
Sulfanitran Pharma./veter. comp. (WS) CAS 122-16-7 Molecular Weight - 335.3351 Storage - RT Catalog Num - DRE-C17000050 chemical
Cayman Chemical Suc-AAPF-pNA 10mg
A chromogenic substrate that can be cleaved by cathepsin G (Km = 1.7 mM), subtilisins, chymotrypsin (Km = 60 µM), chymase (Km = 4 mM), and cyclophilin; used for inhibitor screening and kinetic analysis
Medchemexpress LLC Febantel | 58306-30-2 | 99.9% | 446.48 | 1 ML
Febantel is an oral dewormer used to treat gastrointestinal nematodes in sheep, as well as roundworm and tapeworm infections in poultry and livestock. It also inhibits the embryonic development of mouse hairworms and whipworm eggs.
- Oral dewormer
- Treats gastrointestinal nematodes in sheep
- Treats roundworm and tapeworm infections in poultry and livestock
- Inhibits embryonic development of mouse hairworms and whipworm eggs
- High purity: 99.91%
- Available in solid and solution forms
Selleck Chemical LLC D-Mannosamine hydrochloride S3332-25mg
D-Mannosamine hydrochloride ((2S 3R 4S 5R)-2-Amino-3 4 5 6-tetrahydroxyhexanal hydrochloride) is an active endogenous metabolite
Selleck Chemical LLC S-Ruxolitinib (INCB018424) S2902-1g
S-Ruxolitinib is the chirality of INCB018424 which is the first potent selective JAK1/2 inhibitor to enter the clinic with IC50 of 3 3 nM/2 8 nM 130-fold selectivity for JAK1/2 versus JAK3 Phase 3
Selleck Chemical LLC Metoclopramide HCl S4289-200mg
Metoclopramide HCl(Metoclopramide hydrochloride) is a selective dopamine D2 receptor antagonist used for the treatment of nausea and vomiting
Cayman Chemical N-desmethyl ImatInIb 10mg
A major active metabolite of imatinib; formed through demethylation of imatinib by CYP3A4; has the same in vitro potency at Bcr-ABL kinase as imatinib (IC50 = 38 nM for both) but is only present in plasma at 10-15% of the levels of imatinib